ArticleBMC nephrology2023

Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study.

Metalia Puspitasari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.